Effects of Stress on Glucose Tolerance During Pregnancy
NCT ID: NCT01707784
Last Updated: 2020-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
203 participants
OBSERVATIONAL
2012-10-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objectives of the study are to investigate if various measures of stress (stressful life events, the perceived level of stress and the cortisol or copeptin concentrations) differ between pregnant women with and without gestational diabetes during the end of the second/beginning of the third trimester when presenting for their routine glucose tolerance testing.
Secondary objectives are the link between these different stress measures and the routinely measured fasting and stimulated glucose levels during the oral glucose tolerance test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maternal Emotions and Diet in Pregnancy
NCT03278392
Maternal Stress and Blood Sugar Metabolization
NCT05798377
Insulin Resistance and Hypertensive Disorders in Pregnancy
NCT00412230
Regulation Of Maternal Fuel Supply And Neonatal Adiposity
NCT00826904
Therapeutic Writing to Reduce Stress
NCT03904979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Women with gestational diabetes have more life events compared to pregnant women without gestational diabetes.
2. Women with gestational diabetes have higher perceived level of stress and anxiety compared to pregnant women without gestational diabetes.
3. Women with gestational diabetes have higher measures of cortisol levels in the saliva and in the nailfolds and higher plasma copeptin levels compared to pregnant women without gestational diabetes.
Secondary objectives:
1\. To test the link between these stress measures and the fasting and stimulated glucose levels during the oral glucose tolerance test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with gestational diabetes
Women with gestational diabetes diagnosed by clinically routine 75 g oral glucose tolerance testing
No interventions assigned to this group
Women without gestational diabetes
Women without gestational diabetes diagnosed by clinically routine 75 g oral glucose tolerance testing
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant woman who has the inability to fill out the questionnaires with assistance
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lausanne Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jardena Puder
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jardena J. Puder, MD
Role: STUDY_DIRECTOR
University of Lausanne
Ji-Seon Kang
Role: PRINCIPAL_INVESTIGATOR
University of Lausanne
Yvan Vial, MD
Role: PRINCIPAL_INVESTIGATOR
University of Lausanne
Pr Ulrike Ehlert, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Zurich
Ayala Borghini, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Lausanne
Pedro Marques-Vidal, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Lausanne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maternité CHUV, University of Lausanne
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
295/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.